At the University of New Haven, the health and safety of all members of our community remain our top priority. We have reimagined life at the University to help deliver high-quality education in as safe an environment as possible.
This website provides updated information about our response to the pandemic and our ongoing efforts to prevent the spread of COVID-19, and is being continually updated throughout the Spring 2021 semester.
With widespread availability of several highly effective COVID-19 vaccines, University of New Haven leaders have a high degree of confidence the University will be able to return to many of its pre-pandemic norms in terms of class formats, student life, and other staples of the Charger experience.
Biomedical Engineering Professor Reflects on the Success of Recent Graduate
Kagya Amoako, Ph.D. introduces us to Yaw Ansong Jr. ’19 M.S., who since graduating from the University has created a medical diagnostics company that has collaborated with scientists at Yale and Duke. Soon, he will begin pursuing a Ph.D. at UC Berkeley.
April 29, 2020
By Kagya Amoako, Ph.D.
Yaw Ansong Jr. ’19 M.S. admits he is amazed at how his career has progressed since he graduated from the University of New Haven’s graduate program in biomedical engineering (BME). Originally from Ghana, Yaw practiced medicine in his native country before moving to the U.S. to pursue a graduate degree at the University of New Haven.
“I’ve always loved engineering and technology, and I always knew I wanted to combine my medical knowledge with engineering,” he said. “I didn’t know how I would achieve that until I came to the University of New Haven.
I was not surprised to learn that he was accepted at some of the best institutions in the country. His success is a testament to the University’s graduate program in biomedical engineering’s focus on students and research. His story is not unique in our program.
The skills Yaw developed came in handy when he graduated from the University. While his colleagues were job hunting and receiving offers, he spent time developing his new venture, KovaDx, a medical diagnostics company aiming to fix the health disparity faced by people with sickle cell disease, which was funded through grants.
Working to develop a device that combines 3D phase images with deep learning to make the diagnosis of blood morphological diseases cheaper and easier to perform, the company has research partnerships and collaborations with scientists at Yale and Duke University. It has also been selected for awards and grants including Connecticut Innovation’s biopipeline grant, the Rothberg Prototype Fund Award, and the Rita Wilson Prize Fund from Yale.
‘If there’s anything life has taught me, it's that the right education and the right mentorship opportunities matter,” said Yaw. “I’ll never forget the experiences I had at the University of New Haven.”
Dr. Kagya Amoako is an associate professor of biomedical engineering at the University of New Haven. He is also coordinator of the graduate program in biomedical engineering and director of the University’s Biomaterials and Medical Device Innovation Laboratory.